METiS Therapeutics Revenue and Competitors

Location

$86M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • METiS Therapeutics's estimated annual revenue is currently $3.8M per year.(i)
  • METiS Therapeutics's estimated revenue per employee is $100,500
  • METiS Therapeutics's total funding is $86M.

Employee Data

  • METiS Therapeutics has 38 Employees.(i)
  • METiS Therapeutics grew their employee count by 19% last year.

METiS Therapeutics's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
Co-founder and COOReveal Email/Phone
3
VP, Business Development and StrategyReveal Email/Phone
4
Director ChemistryReveal Email/Phone
5
Senior Director and Head Clinical PharmacologyReveal Email/Phone
6
Associate Director, Facilities & Lab OperationsReveal Email/Phone
7
Associate Director, HRReveal Email/Phone
8
Senior ManagerReveal Email/Phone
9
President, Head R&DReveal Email/Phone
10
Principal ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3240%$634MN/A
#2
$47.8M2380%N/AN/A
#3
$2.4M12-52%N/AN/A
#4
$25.7M12839%N/AN/A
#5
$12.9M64129%N/AN/A
#6
$23.9M1198%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.3M51-14%N/AN/A
#9
$1.8M367-4%$538MN/A
#10
$50M2493%N/AN/A
Add Company

What Is METiS Therapeutics?

The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism- driven quantum mechanics and molecular dynamics simulations to calculate Active Pharmaceutical Ingredient (API) properties, elucidate API-target and API-excipient interactions, and predict chemical, physical and pharmacokinetic properties of small molecule and nucleic acid therapeutics in specific microenvironments. This enables efficient lead optimization, candidate selection and formulation design. Founded by a team of MIT researchers, serial entrepreneurs and biotech industry veterans, METiS develops and in-licenses novel assets with high therapeutic potential that could benefit from its data-driven platform.

keywords:N/A

$86M

Total Funding

38

Number of Employees

$3.8M

Revenue (est)

19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

METiS Therapeutics News

2022-04-06 - Chinese insurers lead $150m rounds in biotech startup METiS

METiS Therapeutics, a China-US biotech startup that integrates drug discovery and delivery with artificial intelligence (AI), announced on...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4M380%$10M
#2
$5.5M38-7%N/A
#3
$4.4M38N/AN/A
#4
$7.5M380%N/A
#5
$4.4M3846%N/A